Cancer treatment using humanized antibodies that bind to EphB4

Details for Australian Patent Application No. 2008287427 (hide)

Owner VasGene Therapeutics, Inc.

Inventors Gill, Parkash; Carr, Francis Joseph; Keen, Simon William; Krasnoperov, Valery; Jones, Timothy David

Agent Shelston IP

Pub. Number AU-A-2008287427

PCT Pub. Number WO2009/023185

Priority 60/964,496 13.08.07 US

Filing date 11 August 2008

Wipo publication date 19 February 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

11 March 2010 PCT application entered the National Phase

  PCT publication WO2009/023185 Priority application(s): WO2009/023185

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008287431-Method for control channel transmission with persistent scheduling

2008287426-Universal fibronectin type III binding-domain libraries